These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 20727477

  • 1. Increasing trend of resistance to nalidixic acid and emerging ceftriaxone and ciprofloxacin resistance in Salmonella enterica serovar Typhimurium in Slovakia, 2005 to 2009.
    Majtan J, Majtanova L, Majtan V.
    Diagn Microbiol Infect Dis; 2010 Sep; 68(1):86-8. PubMed ID: 20727477
    [Abstract] [Full Text] [Related]

  • 2. Increasing incidence of quinolone resistance in human non-typhoid Salmonella enterica isolates in Korea and mechanisms involved in quinolone resistance.
    Choi SH, Woo JH, Lee JE, Park SJ, Choo EJ, Kwak YG, Kim MN, Choi MS, Lee NY, Lee BK, Kim NJ, Jeong JY, Ryu J, Kim YS.
    J Antimicrob Chemother; 2005 Dec; 56(6):1111-4. PubMed ID: 16244086
    [Abstract] [Full Text] [Related]

  • 3. Characterization of isolates of Salmonella enterica serovar typhimurium displaying high-level fluoroquinolone resistance in Japan.
    Izumiya H, Mori K, Kurazono T, Yamaguchi M, Higashide M, Konishi N, Kai A, Morita K, Terajima J, Watanabe H.
    J Clin Microbiol; 2005 Oct; 43(10):5074-9. PubMed ID: 16207965
    [Abstract] [Full Text] [Related]

  • 4. Increase in nalidixic acid resistance among non-Typhi Salmonella enterica isolates in the United States from 1996 to 2003.
    Stevenson JE, Gay K, Barrett TJ, Medalla F, Chiller TM, Angulo FJ.
    Antimicrob Agents Chemother; 2007 Jan; 51(1):195-7. PubMed ID: 17088493
    [Abstract] [Full Text] [Related]

  • 5. Analysis of integrons in human isolates of Salmonella enterica serovar typhimurium isolated in the Slovak Republic.
    Majtán V, Majtánová L, Kovác L.
    FEMS Microbiol Lett; 2004 Oct 01; 239(1):25-31. PubMed ID: 15451097
    [Abstract] [Full Text] [Related]

  • 6. Assessment of factors contributing to changes in the incidence of antimicrobial drug resistance in Salmonella enterica serotypes Enteritidis and Typhimurium from humans in England and Wales in 2000, 2002 and 2004.
    Threlfall EJ, Day M, de Pinna E, Charlett A, Goodyear KL.
    Int J Antimicrob Agents; 2006 Nov 01; 28(5):389-95. PubMed ID: 17029756
    [Abstract] [Full Text] [Related]

  • 7. Emergence of clinical Salmonella enterica serovar Typhimurium isolates with concurrent resistance to ciprofloxacin, ceftriaxone, and azithromycin.
    Wong MH, Yan M, Chan EW, Biao K, Chen S.
    Antimicrob Agents Chemother; 2014 Jul 01; 58(7):3752-6. PubMed ID: 24752251
    [Abstract] [Full Text] [Related]

  • 8. Increasing prevalence of quinolone resistance in human nontyphoid Salmonella enterica isolates obtained in Spain from 1981 to 2003.
    Marimón JM, Gomáriz M, Zigorraga C, Cilla G, Pérez-Trallero E.
    Antimicrob Agents Chemother; 2004 Oct 01; 48(10):3789-93. PubMed ID: 15388435
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Molecular characterisation of multidrug-resistant Salmonella enterica serovar Typhimurium isolates from Gomel region, Belarus.
    Tapalski D, Hendriksen RS, Hasman H, Ahrens P, Aarestrup FM.
    Clin Microbiol Infect; 2007 Oct 01; 13(10):1030-3. PubMed ID: 17697002
    [Abstract] [Full Text] [Related]

  • 11. Characterization of multidrug-resistant Salmonella enterica serovar Typhimurium isolated in Japan.
    Izumiya H, Terajima J, Matsushita S, Tamura K, Watanabe H.
    J Clin Microbiol; 2001 Jul 01; 39(7):2700-3. PubMed ID: 11427600
    [Abstract] [Full Text] [Related]

  • 12. Multidrug-resistant strains of Salmonella enterica Typhimurium, United States, 1997-1998.
    Rabatsky-Ehr T, Whichard J, Rossiter S, Holland B, Stamey K, Headrick ML, Barrett TJ, Angulo FJ, NARMS Working Group.
    Emerg Infect Dis; 2004 May 01; 10(5):795-801. PubMed ID: 15200811
    [Abstract] [Full Text] [Related]

  • 13. Molecular characterization of the multidrug-resistant phage types Salmonella enterica serovar Typhimurium DT104, DT20A and DT120 strains in the Slovakia.
    Majtánová L, Majtán V.
    Microbiol Res; 2009 May 01; 164(2):157-62. PubMed ID: 17306968
    [Abstract] [Full Text] [Related]

  • 14. Surveillance of antibiotic resistance evolution and detection of class 1 and 2 integrons in human isolates of multi-resistant Salmonella Typhimurium obtained in Uruguay between 1976 and 2000.
    Macedo-Viñas M, Cordeiro NF, Bado I, Herrera-Leon S, Vola M, Robino L, Gonzalez-Sanz R, Mateos S, Schelotto F, Algorta G, Ayala JA, Echeita A, Vignoli R.
    Int J Infect Dis; 2009 May 01; 13(3):342-8. PubMed ID: 18977678
    [Abstract] [Full Text] [Related]

  • 15. A new therapeutic challenge for old pathogens: community-acquired invasive infections caused by ceftriaxone- and ciprofloxacin-resistant Salmonella enterica serotype choleraesuis.
    Ko WC, Yan JJ, Yu WL, Lee HC, Lee NY, Wang LR, Chuang YC.
    Clin Infect Dis; 2005 Jan 15; 40(2):315-8. PubMed ID: 15655754
    [Abstract] [Full Text] [Related]

  • 16. Impact of quinolone-resistance acquisition on biofilm production and fitness in Salmonella enterica.
    Fàbrega A, Soto SM, Ballesté-Delpierre C, Fernández-Orth D, Jiménez de Anta MT, Vila J.
    J Antimicrob Chemother; 2014 Jul 15; 69(7):1815-24. PubMed ID: 24706735
    [Abstract] [Full Text] [Related]

  • 17. Predictive value of nalidixic acid resistance for detecting salmonellae with decreased ciprofloxacin susceptibility.
    Albayrak F, Cokca F, Erdem B, Aysev AD.
    Int J Antimicrob Agents; 2004 Apr 15; 23(4):332-6. PubMed ID: 15081080
    [Abstract] [Full Text] [Related]

  • 18. Travel-acquired salmonellosis due to Salmonella Kentucky resistant to ciprofloxacin, ceftriaxone and co-trimoxazole and associated with treatment failure.
    Collard JM, Place S, Denis O, Rodriguez-Villalobos H, Vrints M, Weill FX, Baucheron S, Cloeckaert A, Struelens M, Bertrand S.
    J Antimicrob Chemother; 2007 Jul 15; 60(1):190-2. PubMed ID: 17449886
    [No Abstract] [Full Text] [Related]

  • 19. Nalidixic acid resistance in Salmonella strains with decreased susceptibility to ciprofloxacin isolated from humans in Turkey.
    Ercis S, Erdem B, Hasçelik G, Gür D.
    Jpn J Infect Dis; 2006 Apr 15; 59(2):117-9. PubMed ID: 16632912
    [Abstract] [Full Text] [Related]

  • 20. Emergence of multidrug-resistant Salmonella spp. and isolates with reduced susceptibility to ciprofloxacin in Kuwait and the United Arab Emirates.
    Rotimi VO, Jamal W, Pal T, Sonnevend A, Dimitrov TS, Albert MJ.
    Diagn Microbiol Infect Dis; 2008 Jan 15; 60(1):71-7. PubMed ID: 17931817
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.